GeneMatch designed to speed up Alzheimer’s trial recruitment
December 9, 2015|Clinical Neurology News
Author and Disclosure Information
GeneMatch is not only an important research tool, Dr. Tariot said, but a way that anyone can take part in the search for an Alzheimer’s treatment.
“This process changes the role people can play in research. Families of patients often feel helpless after a diagnosis, but GeneMatch can give them the opportunity to take action, to be part of the movement to end this before another generation is lost.”
